Market Size in 2023 | Market Forecast in 2032 | Growth Rate (in %) | Base Year |
---|---|---|---|
USD 172.53 Million | USD 546.61 Million | CAGR at 13.67% | 2023 |
According to the report published by Zion Market Research, the global Needle Free Injection System Market size was valued at USD 172.53 Million in 2023 and is predicted to reach USD 546.61 Million by the end of 2032. The market is expected to grow with a CAGR of 13.67% during the forecast period. The report analyzes the global Needle Free Injection System Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Needle Free Injection System Market industry.
Needle-free injection system is a technology that assists in introducing medications into the body of the patient. It is different from the conventional needle system where a needle was injected through the skin. The needle-free injection system is an efficient way to administer such medication. These needle-free systems are preferred because it has significantly increased the immune response to vaccines and lowered the healthcare costs along with the potential risks associated with needles.
The growing incidences and prevalence of chronic disease along with the surging number of communicable diseases caused by needle injuries are driving the global needle free injection system market vigorously. Moreover, the needle-free injection technology eliminates the problem of bleeding or bruising and skin puncture hazards. Different organizations across the globe like WHO and CDC are supporting the development of needle-free options for delivering medicines to the human body. They also expect the technology to create immense growth opportunities in the coming years in the global needle free injection system market.
Human skin is highly immunogenic and thus needle-free injection develops an effective immune response to vaccines. The growing complications arising from using a single needle for multiple uses and the probability of needle-stick injuries are expected to further boost the growth of the global needle free injection system market significantly during the forecast period. Such a system facilitates the delivery of a wide number of drugs into the human body. The administration of the highly viscous drug is possible with the innovative needle-free injector system. However, the administration of such medicine was not possible with traditional serial systems.
Moreover, it is a painless method of administering drugs to the human body with the help of shock waves, pressure, or electrophoresis. Needle-free injections apparently minimize the phobia of needles in the patients. Nowadays, an increasing number of patients are using self-administered drugs using needle-free injection systems. Such needle-free injectors can be completely customized according to the requirement by the patients and thus modified to optimize productivity.
The global needle free injection system market can be segmented into the distribution channel, application, site of delivery, medication, technology, product, and region.
By distribution channel, the market can be segmented into ambulatory surgical centers, research laboratories, home care settings, clinics, hospitals, and others. The hospital segment accounts for the largest share in the global needle free injection system market.
By application, the market can be segmented into pediatric injections, pain management, insulin delivery, vaccine delivery, and others.
By site of delivery, the market can be segmented into subcutaneous injectors, intramuscular injectors, and intradermal injectors. The subcutaneous injectors segment holds hegemony over others.
By medication, the market can be segmented into depot-based needle free injectors, powder-based needle free injectors, and liquid-based needle free injectors.
By technology, the market can be segmented into vibration-based needle free injectors, laser-powered needle free injectors, spring-based needle free injectors, and jet-based needle free injectors.
By product, the market can be segmented into fillable needle free injectors and pre-filled needle free injectors.
Report Attributes | Report Details |
---|---|
Report Name | Needle Free Injection System Market Research Report |
Market Size in 2023 | USD 172.53 Million |
Market Forecast in 2032 | USD 546.61 Million |
Growth Rate | CAGR of 13.67% |
Number of Pages | 196 |
Key Companies Covered | Crossject, Penject, European Pharma, Valeritas, National Medical Products, Injex Pharma, Medical International Technology, Bioject Medical Technologies, Pharmajet, Endo International, and Antares Pharma |
Segments Covered | By Distribution channel, By Application, By Site of delivery, By Medication, By Technology, By Product and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America holds the largest share in the global needle free injection system market due to the increasing prevalence of chronic diseases like cancer and diabetes. Moreover, the growing demand of patients for self-administration of drugs through needle-free injections is further driving the growth of the regional market.
Asia Pacific is anticipated to witness huge growth during the forecast period due to the growing inclination of the patient towards the advanced technologies and growing demand for biologics & needle-free injection for self-administration of drugs. Moreover, the increasing investments to strengthen the healthcare expenditure in the region along with boosting the research and development activities to develop more advanced needle-free systems for proper & effective administration of drugs will boost the regional market.
Some of the significant players in the global needle free injection system market are:
By Distribution channel
By Application
By Site of delivery
By Medication
By Technology
By Product
FrequentlyAsked Questions
The growing incidences and prevalence of chronic disease along with the surging number of communicable diseases caused by needle injuries are driving the global needle free injection system market vigorously. Moreover, the needle-free injection technology eliminates the problem of bleeding or bruising and skin puncture hazards. Different organizations across the globe like WHO and CDC are supporting the development of needle-free options for delivering medicines to the human body.
Some of the significant players in the global needle free injection system market are Crossject, Penject, European Pharma, Valeritas, National Medical Products, Injex Pharma, Medical International Technology, Bioject Medical Technologies, Pharmajet, Endo International, and Antares Pharma.
North America holds the largest share in the global needle free injection system market due to the increasing prevalence of chronic diseases like cancer and diabetes. Moreover, the growing demand of patients for self-administration of drugs through needle-free injections is further driving the growth of the regional market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed